📰 Abt News
Page 180 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 10, 2023
Progressive Investment Management Corp cut its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 11.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,103 shares of the healthcare product maker’s stock after selling 270 shares during the period. Progressive Investment […]
April 10, 2023
Comprehensive Financial Consultants Institutional Inc. lifted its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 1.5% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 8,948 shares of the healthcare product maker’s stock after acquiring an additional 136 shares during the period. Comprehensive Financial Consultants […]
April 10, 2023
Folger Nolan Fleming Douglas Capital Management Inc. lifted its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 4.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 95,622 shares of the healthcare product maker’s stock after purchasing an additional 4,201 shares […]
April 10, 2023
Cahaba Wealth Management Inc. increased its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 6.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,174 shares of the healthcare product maker’s stock after acquiring an additional 318 shares […]
April 10, 2023
Stewart & Patten Co. LLC lowered its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 1.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 195,675 shares of the healthcare product maker’s stock after selling 3,159 shares during the period. Abbott Laboratories accounts for about 3.7% of Stewart & Patten Co. LLC’s portfolio, making […]
April 10, 2023
Signaturefd LLC lowered its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 1.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 42,272 shares of the healthcare product maker’s stock after selling 537 shares during the period. Signaturefd LLC’s holdings in […]
April 10, 2023
Howland Capital Management LLC grew its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 8.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 33,898 shares of the healthcare product maker’s stock after acquiring an additional 2,748 shares during the quarter. […]
April 10, 2023
James Investment Research Inc. lowered its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 78,433 shares of the healthcare product maker’s stock after selling 3,535 shares during the quarter. […]
April 10, 2023
First Interstate Bank trimmed its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 3.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,288 shares of the healthcare product maker’s stock after selling 919 shares during the quarter. […]
April 10, 2023
Parnassus Investments LLC reduced its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 40.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,966,714 shares of the healthcare product maker’s stock after selling 2,006,873 shares during the period. Parnassus Investments LLC owned about 0.17% of Abbott Laboratories […]